| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9708 |
| Human Intestinal Absorption | HIA+ | 0.9954 |
| Caco-2 Permeability | Caco2+ | 0.7322 |
| P-glycoprotein Substrate | Substrate | 0.9173 |
| P-glycoprotein Inhibitor | Inhibitor | 0.7399 |
| Non-inhibitor | 0.7779 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6479 |
| Distribution |
| Subcellular localization | Mitochondria | 0.3579 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8713 |
| CYP450 2D6 Substrate | Substrate | 0.7349 |
| CYP450 3A4 Substrate | Substrate | 0.7858 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9392 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8992 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.6197 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8553 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8272 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9294 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8072 |
| Non-inhibitor | 0.7219 |
| AMES Toxicity | Non AMES toxic | 0.7862 |
| Carcinogens | Non-carcinogens | 0.9372 |
| Fish Toxicity | High FHMT | 0.9488 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9974 |
| Honey Bee Toxicity | High HBT | 0.5385 |
| Biodegradation | Not ready biodegradable | 0.9973 |
| Acute Oral Toxicity | III | 0.4760 |
| Carcinogenicity (Three-class) | Non-required | 0.5991 |